Effects of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan: results from the phase 2 RESCUE-2 trial
Event:
ESC Congress 2022
Topic:
Renal Failure and Cardiovascular Disease
Session:
Renal failure and cardiovascular disease 2
